Perspective insights into hydrogels and nanomaterials for ischemic stroke release_jowrn6pa5zh77adzhh77qa4n7e

by Qingbo Yu, Zhang Jian, Dan Yang, Tao Zhu

Published in Frontiers in Cellular Neuroscience by Frontiers Media SA.

2023   Volume 16, p1058753


Ischemic stroke (IS) is a neurological disorder prevalent worldwide with a high disability and mortality rate. In the clinic setting, tissue plasminogen activator (tPA) and thrombectomy could restore blood flow of the occlusion region and improve the outcomes of IS patients; however, these therapies are restricted by a narrow time window. Although several preclinical trials have revealed the molecular and cellular mechanisms underlying infarct lesions, the translatability of most findings is unsatisfactory, which contributes to the emergence of new biomaterials, such as hydrogels and nanomaterials, for the treatment of IS. Biomaterials function as structural scaffolds or are combined with other compounds to release therapeutic drugs. Biomaterial-mediated drug delivery approaches could optimize the therapeutic effects based on their brain-targeting property, biocompatibility, and functionality. This review summarizes the advances in biomaterials in the last several years, aiming to discuss the therapeutic potential of new biomaterials from the bench to bedside. The promising prospects of new biomaterials indicate the possibility of an organic combination between materialogy and medicine, which is a novel field under exploration.
In application/xml+jats format

Archived Files and Locations

application/pdf  2.2 MB
file_v3d7txpnabbmnbohnnzmnhn5yu (publisher) (webarchive)
Read Archived PDF
Preserved and Accessible
Type  article-journal
Stage   published
Date   2023-01-24
Language   en ?
Container Metadata
Open Access Publication
In Keepers Registry
ISSN-L:  1662-5102
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: fb238f2f-ea75-40b9-acf7-9fc2ef16bf41